Alnylam Pharmace. buy Wolf_of_WS
Start price
23.06.24
/
50%
€154.85
Target price
23.06.25
-
Performance (%)
35.23%
End price
24.06.24
€209.40
Summary
This prediction ended on 24.06.24 with a price of €209.40. The BUY prediction by Wolf_of_WS for Alnylam Pharmace. saw massive gains of 35.23%. Wolf_of_WS has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Alnylam Pharmace. | 46.434% |
| iShares Core DAX® | 0.238% |
| iShares Nasdaq 100 | -0.304% |
| iShares Nikkei 225® | 2.271% |
| iShares S&P 500 | -0.296% |
Comments by Wolf_of_WS for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.